Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 29 ... eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breastcancer and osteoporosis.Published in this week's (Nov. 9) Proceedings of ...
2009 NOV 23 ... of $5 million to Halozyme. Roche intends to enroll 552 patients with HER2-positive breastcancer in the study. Roche also initiated a Phase 1 pharmacokinetic ...
2009 NOV 23 ... company now in Phase I/II FDA-authorized trials testing the safety and efficacy of its breastcancer immunotherapy treatment. Quantum CEO, Chuck Broes, reported to ...
2009 NOV 24 ... in developing PET system. In addition, Aurora developed the AURORA Spiral RODEO™ Breast, the first and currently the only FDA-certified magnetic resonance imaging (MRI) ... instrument for breast MRI, like mammogram, which provides early diagnosis of breast cancer at very early stage to save lives of many ill women. Gene and Olivia, both originally ...
2009 NOV 23 ... on a linear ion trap was utilized to identify and compare serum proteins from breastcancer patients." "Three groups of 21 human sera, 7 from patients with ...
2009 NOV 23 ... (atypical ductal hyperplasia and/or ductal carcinoma in situ) and invasive ductal breast carcinoma from 52 patients, together with pure lesions from 24 patients and 12 normal ... and this epigenetic change has been considered as a potential molecular marker for cancer. We examined the methylation status of nine genes (APC, CDH1, CTNNB1, TIMP3, ESR1, ...
2009 NOV 23 ... treatment protocols. Not all patients treated with trastuzumab (indication: breastcancer) and cetuximab (indication: metastatic colorectal cancer) respond well even when ...
2009 NOV 23 ... This is a wonderful opportunity to help spread awareness and raise vital funds for breastcancer," stated Charles P. Thompson, Board President of the Phoenix Affiliate of Susan ...
2009 NOV 23 ... regulatory gene in plasma DNA from blood collected before diagnosis from women with breastcancer and from controls. Samples were from two sets of subjects, 28 women with breast ...
2009 NOV 23 ... United States, "Sentinel lymph node (SLN) surgery is widely used for nodal staging in early-stage breast cancer This study was pet-formed to evaluate the accuracy of SLN surgery for patients ...
2009 NOV 23 ... "We sought to evaluate factors influencing the choice of surgery for women with early-stage breast cancer. Between 1996 and 2005, 47,837 women who were diagnosed with Stage I breast cancer ...
2009 NOV 23 ... p=0.003). Great increase of incidence by time was found (R(2)=0.90; p=0.004). Breast, prostate and bladder cancers increase risk of second tumor in female genital organs [RR ... Researchers detail in 'Multiple primary cancer: an increasing health problem. Strategies for prevention in cancer survivors,' new data ...
2009 NOV 23 ... Researchers detail in 'Sonographic changes after removing all benign breast masses with sonographically guided vacuum-assisted biopsy,' new data in biopsy. ... changes on follow-up sonography after 6 months," wrote E.S. Ko and colleagues, Korea Cancer Center Hospital, Department of Radiology. The researchers concluded: ...
2009 NOV 23 ... offering SAVI™ radiation treatment as part of breast conservation therapy for early-stage breast cancer - a major milestone in breast brachytherapy. Leanna Elder became the first ...
2009 NOV 23 ... aromatase inhibitors: what the general internist needs to know,' is now available. "Breastcancer patients represent the largest group of adult cancer survivors in the US. Most ...
2009 NOV 23 ... control was women with negative Pap smear and second group of control was the women with breastcancer but negative Pap smear." "A total of 100 biopsy-proven cases of ...
2009 NOV 23 ... in the September issue of Oncology Nursing Forum, women who were diagnosed with early-stage breast cancer were interviewed during the period just after surgical consultation and before surgery. ...
2009 NOV 23 ... Larry Norton. The Company expects to initiate a Phase I/II study of oral indibulin in breastcancer patients employing this dosing schedule established preclinically. Once the ...
2009 NOV 23 ... Oral indibulin (ZybulinTM or ZIO-301) is scheduled to enter into a Phase I/II study in breastcancer patients using the Norton-dosing schedule developed preclinically with Dr. Larry ...
